Lotus Herbals acquires 32% stake in Fixderma India
Earlier the brand bought 100% stake in organic Ayurveda brand Soul Tree
image for illustrative purpose
New Delhi: Beauty and personal care products maker Lotus Herbals has bought a 32 percent stake in Fixderma India, owners of dermaceuticals brands like Fixderma and FCL.
The company, however, did not disclose the financial details of the transaction. Through this investment, Lotus Herbals forays into the dermaceutical segment offering a premium range of skincare and haircare products, said a joint statement. This also bridges the gap between the prescription-based products and over-the-counter cosmetics, it added. "By investing in this leading cosmeceutical company, Lotus enters the dermaceutical beauty space with a clear-sighted goal of emerging as domain leaders in the future," it said.
Fixderma, along with its premium skincare range FCL, manufactures dermatology products. It is an established direct-to-consumer (D2C) brand and Fixderma product lines are also retailed through dermatologists and pharmacies in India and overseas. "With our strategic planning & marketing expertise, we aim at enhancing the global footprint for Fixderma and FCL and capture significant market share within the next five years as part of our long-term growth strategy," Lotus Herbals Joint Managing Director Nitin Passi said.
